Activist fund Sarissa said to seek Ariad CEO change
February 12, 2015 at 17:24 PM EST
Activist hedge fund Sarissa Capital, which won a seat on Ariad Pharmaceuticals' board last year, is seeking to replace the company's CEO and may mount a proxy fight, according to a person familiar with the hedge fund's plans.
